Immuneering Corporation
IMRX
$1.45
-$0.01-0.69%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -14.15% | -12.46% | -8.06% | -5.77% | -5.86% |
| Total Depreciation and Amortization | 9.34% | -54.73% | -55.45% | -55.65% | -55.81% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 28.33% | 45.81% | 42.11% | 35.25% | 31.48% |
| Change in Net Operating Assets | 5.05% | 69.24% | -60.57% | -836.15% | -156.76% |
| Cash from Operations | -12.32% | -6.79% | -6.90% | -8.23% | -11.04% |
| Capital Expenditure | 75.20% | -2.24% | 48.31% | 46.26% | 53.85% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 247.15% | 93.71% | -83.83% | -79.47% | -82.06% |
| Cash from Investing | 262.30% | 95.50% | -84.41% | -79.92% | -82.56% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -81.04% | -81.34% | -96.48% | 8,375.71% | 9,435.55% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 37.49% | 100.00% | 100.00% | 27.58% | 27.58% |
| Cash from Financing | -81.35% | -81.05% | -96.42% | 44,588.36% | 149,589.47% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -75.81% | -172.57% | -375.43% | -600.77% | -487.70% |